Search

Your search keyword '"Merino, Esperanza"' showing total 333 results

Search Constraints

Start Over You searched for: Author "Merino, Esperanza" Remove constraint Author: "Merino, Esperanza" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
333 results on '"Merino, Esperanza"'

Search Results

2. Safety and effectiveness of isavuconazole in real-life non-neutropenic patients

4. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

7. How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations

9. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

10. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

13. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

15. An integrated emergency department/hospital at home model in mild COVID-19 pneumonia: feasibility and outcomes after discharge from the emergency department

18. Enhanced recovery after low- and medium-risk liver transplantation. A single-center prospective observational cohort study

19. Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients

20. Comparison of Different Methods for Assaying the In Vitro Activity of Cefiderocol against Carbapenem-Resistant Pseudomonas aeruginosa Strains: Influence of Bacterial Inoculum.

21. Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015

22. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

23. Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort

24. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

25. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

27. Corrigendum to “Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients” [International Journal of Infectious Diseases 144 (2024) 107070]

28. High delayed mortality after the first episode of Clostridium difficile infection

29. Role of age and comorbidities in mortality of patients with infective endocarditis

30. A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status

31. Rationale for combined therapies in severe-to-critical COVID-19 patients

32. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

33. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

34. Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse

37. Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

38. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients

39. Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin

40. Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment

41. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes

42. Rationale for combined therapies in severe-to-critical COVID-19 patients

43. Transient changes in the plasma of astrocytic and neuronal injury biomarkers in COVID-19 patients without neurological syndromes

44. Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin

45. Rationale for combined therapies in severe-to-critical COVID-19 patients

46. Perinatal exposure to pesticides alters synaptica plasticity signaling and induces behavioral deficits associated with neurodevelopment disorders

49. Effectiveness and Safety of a Structured De-Escalation from Antipseudomonal Β-Lactams in Bloodstream Infections Due to Enterobacterales: A Multicentre Randomised Clinical Trial (SIMPLIFY)

50. Infección leve por SARS-CoV-2 en pacientes vulnerables: implantación de una vía clínica de tratamiento precoz

Catalog

Books, media, physical & digital resources